Neurovascular disorders such as stroke and vascular dementia are among the most relevant medical conditions in Western societies. They also represent major reasons of death and are among the leading causes of functional and cognitive decline in adulthood. Despite intensive research throughout the past decades, treatment options for neurovascular disorders are scarce. This sharply contrasts the tremendous burden they inflict to patients, their relatives, medical care providers, and the entire society.
Neurovascular diseases are strongly associated with prelavent comorbidities such as hypertension or elevated blood fats. Our group is interested in how these comorbidities contribute to pathophysiological sequelae of neurovascular disorders such as neuroinflammation, and how they may affect the impact of experimental therapeutics. We are specialised in translational research strategies and aim to apply experimental settings closely mimicking the situation of human patients as well as potential clinical scenarios. This is important to thoroughly assess the "real world relevance" of basic research findings and to efficiently strengthen and refine future treatment strategies for neurovascular disorders.
The ultimate aim of our research is to contribute to a better understanding of the complex pathophysiology of neurovascular disorders and to use this knowledge to increase the therapeutic efficiency of novel treatments.
2012. PhD (Dr. rer. nat.) University of Leipzig
2008. Dr. med. University of Leipzig
2016-present. Member, American Society for Neural Therapy and Repair
2011-present. Member, Faculty of 1000, Cerebrovascular Disease Section
2006-present. Member, Society for Neuroscience
2006-present. Member, Society for Cerebral Blood Flow and Metabolism
2011-2016. Member, Fraunhofer Vintage Class 2009-2011. Faculty of 1000, Associate Member to Dr. Moskowitz, Cerebrovascular Disease Section
2017-present. Journal of Cerebral Blood Flow and metabolism - editorial board member
2015-present. Metabolic Brain Disease - deputy chief editor
2015-present. Cell Transplantation - section editor, neuroscience and tissue engineering
2015-present. Stroke - editorial board member
2014-present. Translational Stroke Research - editorial board member
2014-present. Acta neurobiologicae experimentalis - editorial board member
2014-present. PLoS One - academic editor